Biogen Inc. (BIIB)
NASDAQ · Healthcare
Biogen Inc. Long Term Debt 2007–2025
Biogen Inc. annual long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Biogen Inc. long term debt as of December 31, 2025: 6.29B, a 38.26% increase year-over-year.
- Biogen Inc. long term debt for 2025 were 6.29B, a 38.26% increase from 2024.
- Biogen Inc. long term debt for 2024 were 4.55B, a 33.01% decrease from 2023.
- Biogen Inc. long term debt for 2023 were 6.79B, a 8.08% increase from 2022.
- Biogen Inc. long term debt for 2022 were 6.28B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Biogen Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $6,287 |
| 2024 | $4,547 |
| 2023 | $6,788 |
| 2022 | $6,281 |
| 2021 | $6,274 |
| 2020 | $7,426 |
| 2019 | $4,459 |
| 2018 | $5,937 |
| 2017 | $5,935 |
| 2016 | $6,513 |
| 2015 | $6,522 |
| 2014 | $580 |
| 2013 | $592 |
| 2012 | $687 |
| 2011 | $1,024 |
Biogen Inc. Long Term Debt — FAQ
Biogen Inc. (BIIB) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIIB's long term debt history?
The chart and table above show Biogen Inc.'s long term debt by year and by quarter, including the growth rate.